Evidence mapPaperPMID 41471302Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Reinvestigating Pyrrol-2-One-Based Compounds: From Antimicrobial Agents to Promising Antitumor Candidates.

Natalia Simionescu, Ashraf Al-Matarneh, Ionel I Mangalagiu, Narcis Cibotariu, Cristina Mariana Uritu, Cristina Maria Al-Matarneh, Mariana Pinteala

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Natalia SimionescuCentre of Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macrmoleclar Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.ORCID 0000-0001-5581-4624
Ashraf Al-MatarnehCentre of Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macrmoleclar Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.
Ionel I MangalagiuFaculty of Chemistry, Alexandru Ioan Cuza University of Iasi, 11 Carol I, 700506 Iasi, Romania.ORCID 0000-0002-4632-5076
Narcis CibotariuCentre of Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macrmoleclar Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.ORCID 0009-0001-7932-7983
Cristina Mariana UrituAdvanced Center for Research and Development in Experimental Medicine "Prof. Ostin C. Mungiu", "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0002-7563-1267
Cristina Maria Al-MatarnehCentre of Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macrmoleclar Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.ORCID 0000-0001-9299-1347
Mariana PintealaCentre of Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macrmoleclar Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.ORCID 0000-0002-4021-982X

Funding

The Health Program (PS) 2021-2027 "Development of translational research for vaccines, serums and other biological drugs-Acronym CANTAVAC 2.0", SMIS code 326920.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antitumor activityiodineosteosarcomapyrrol-2-one

Identifiers

PMID41471302
PMCPMC12736255

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.